Gilead enters into licensing agreement with biotech company

06-09-2018

Gilead enters into licensing agreement with biotech company

solidcolours / iStockphoto.com

US-based Gilead announced Tuesday, September 4 that it has entered into a licensing agreement with biotech company Trianni for an undisclosed sum.


Gilead, Trianni, licensing agreement, deal, antibodies, technology, biotech, partnership, Bill Lee, Matthias Wable

LSIPR